• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Belite Bio, Inc - American Depositary Shares (NQ:BLTE)

173.99 -3.80 (-2.14%)
Streaming Delayed Price Updated: 3:53 PM EST, Mar 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 120,693
Open 177.79
Bid (Size) 173.29 (200)
Ask (Size) 174.68 (100)
Prev. Close 177.79
Today's Range 172.70 - 178.93
52wk Range 49.00 - 200.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Belite Bio (BLTE) Q4 2025 Earnings Call Transcript ↗
March 03, 2026
Belite Bio (BLTE) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Belite Bio to Participate in the Leerink Global Healthcare Conference
March 02, 2026
From Belite Bio, Inc
Via GlobeNewswire

Performance

YTD
+9.2%
+9.2%
1 Month
+0.4%
+0.4%
3 Month
+14.6%
+14.6%
6 Month
+174.0%
+174.0%
1 Year
+191.0%
+191.0%

More News

Read More
Belite Bio Inc - ADR (NASDAQ:BLTE) Reports Narrower-Than-Expected Q4 Loss, NDA Submission on Track for 2026 ↗
March 02, 2026
Via Chartmill
News headline image
Belite Bio Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
March 02, 2026
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Earnings Scheduled For November 10, 2025 ↗
November 10, 2025
Via Benzinga
News headline image
Earnings Outlook For Belite Bio ↗
November 07, 2025
Via Benzinga
News headline image
Belite Bio to Host Webcast on March 2, 2026, to Discuss Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results
February 23, 2026
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio Announces Participation at the 41st Asia-Pacific Academy of Ophthalmology Congress (APAO)
January 29, 2026
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio Completes Enrollment in the DRAGON II Clinical Trial of Tinlarebant for Stargardt Disease (STGD1)
January 27, 2026
From Belite Bio, Inc
Via GlobeNewswire
InvestorNewsBreaks – Belite Bio, Inc (NASDAQ: BLTE) Prices $350M Underwritten Public Offering of ADSs
December 05, 2025
Via Investor Brand Network
News headline image
Belite Bio Announces Pricing of $350.0 Million Underwritten Public Offering of American Depositary Shares
December 01, 2025
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Why Belite Bio Stock Soared on Monday ↗
December 01, 2025
Via The Motley Fool
News headline image
Belite Bio Announces Proposed Underwritten Public Offering of American Depositary Shares
December 01, 2025
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Top movers in Monday's pre-market session ↗
December 01, 2025
Via Chartmill
News headline image
New Hope for People Living with a Disease Once Deemed Untreatable: Belite Bio Announces Positive Topline Results from the Pivotal Global, Phase 3 DRAGON Trial of Tinlarebant in Adolescents with Stargardt Disease
December 01, 2025
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
November 10, 2025
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
November 05, 2025
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results
November 03, 2025
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio Announces UK’s Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
November 02, 2025
From Belite Bio, Inc
Via GlobeNewswire
News headline image
CORRECTION -- International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025
October 31, 2025
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025
October 30, 2025
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Belite Bio to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference November 4th
October 29, 2025
From Virtual Investor Conferences; Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio to Participate in the Deutsche Bank ADR Virtual Investor Conference
October 29, 2025
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio to Participate in the 2025 Maxim Growth Summit
October 16, 2025
From Belite Bio, Inc
Via GlobeNewswire
News headline image
Belite Bio Announces China NMPA Agrees to New Drug Application with Priority Review based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
October 15, 2025
From Belite Bio, Inc
Via GlobeNewswire

Frequently Asked Questions

Is Belite Bio, Inc - American Depositary Shares publicly traded?
Yes, Belite Bio, Inc - American Depositary Shares is publicly traded.
What exchange does Belite Bio, Inc - American Depositary Shares trade on?
Belite Bio, Inc - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Belite Bio, Inc - American Depositary Shares?
The ticker symbol for Belite Bio, Inc - American Depositary Shares is BLTE on the Nasdaq Stock Market
What is the current price of Belite Bio, Inc - American Depositary Shares?
The current price of Belite Bio, Inc - American Depositary Shares is 173.99
When was Belite Bio, Inc - American Depositary Shares last traded?
The last trade of Belite Bio, Inc - American Depositary Shares was at 03/05/26 03:53 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap